Atlas Trials

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)

Clinical trial NCT01031030 · UNKNOWN

Trial details

NCT number
NCT01031030
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
1997-11-01
Primary completion
2010-12-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.